Interleukin-6 levels in tension headache patients

Clinical Journal of Pain

Volumn 26, Issue 8, 2010, Pages 690-693

  Koçer, Abdulkadir ^a   Koçer, Emel ^b   Memişoǧullari, Ramazan ^a   Domaç, Füsun M ^c   Yüksel, Hatice ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b Düzce Atatürk State Hospital   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

inflammation; interleukins; pain; tension type headache

Indexed keywords

INTERLEUKIN 6;

ADOLESCENT; ADULT; ARTICLE; CHRONIC TENSION HEADACHE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EPISODIC TENSION HEADACHE; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; TENSION HEADACHE; VASCULITIS;

EID: 77957232477     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181e8d9b6     Document Type: Article

References (22)

1. Gergont A, Kaciń ski M, Kwinta P. Proinflammatory cytokines in children with idiopathic headache (abstract). Przegl Lek. 2005;62:1269.
2. Ashina M, Bendtsen L, Jensen R, et al. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tensiontype headache. Brain. 1999;122:1629-1635. (Pubitemid 29425667)
3. Vanast WJ, Diaz-Mitoma F, Tyrrell DLJ. Hypothesis: chronic benign daily headache is an immune disorder with a viral trigger. Headache. 1987;27:138-142. (Pubitemid 18003024)
4. Saper JR. Daily chronic headache. Neurol Clin. 1990; 8:891-901.
5. Castillo J, Munoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache. 1999; 39:190-196. (Pubitemid 29190083)
6. Fernández-de-las-Peñas C, Cuadrado ML, Arendt-Nielsen L, et al. Myofascial trigger points and sensitization: an updated pain model for tension-type headache. Cephalalgia. 2007;27: 383-393.
7. Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22:66-69. (Pubitemid 34626027)
8. Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor a levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007;47:1050-1055. (Pubitemid 47057216)
9. Jeong HJ, Hong SH, Nam YC, et al. The effect of acupuncture on proinflammatory cytokine production in patients with chronic headache: a preliminary report. Am J Chin Med. 2003; 31:945-954.
10. Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgia and Facial Pain. 2nd ed. Cephalagia. 2004:24:1-2160.
11. Southern P, Oldstone MBA. Medical consequences of persistent viral infections. NEJM. 1986;314:359-366. (Pubitemid 16166263)
12. Oldstone MBA, Sinha YN, Blount P, et al. Virusinduced alterations in homeostasis; alterations in differentiated functions of infected cells in vivo. Science. 1982;218: 1125-1127. (Pubitemid 13223314)
13. Szoke B. Condyloma accuminatum treated with human leukocyte interferon. J Urol. 1986;135:1247-1248. (Pubitemid 16095884)
14. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157: 683-694. (Pubitemid 30249643)
15. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol. 1992;263:1-16.
16. Rubin LA, Graham D, Pasker R, et al. Autonomic nervous system dysfunction in common migraine. Headache. 1985; 25:40-48. (Pubitemid 15162052)
17. Kuritzky A, Appel S, Zahavi I, et al. Detection of autonomic imbalance using spectoral analysis of heart rate fluctuations in migrainous patients. (Abstract) Headache. 1985;26:310.
18. Ahmed SA, Penhal WJ, Talal N. Sex hormones, immune responses and autoimmune diseases. Mechanisms of sex hormone action. Review article. Am J Pathol. 1985;121:531-551. (Pubitemid 16183373)
19. Peres MFP, Sanchez del Rio M, Seabra MLV, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71:747-751. (Pubitemid 33121915)
20. Roszman TL, Brooks WH. Neural modulation of immune function. J Neuro-immunol. 1985;10:59-69.
21. Maes M, Bosmans E, Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-858. (Pubitemid 27494150)
22. Rief W, Pilger F, Ihle D, et al. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001;105:165-174. (Pubitemid 34117644)